| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/22/2009 | CA2397554C Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 09/22/2009 | CA2369451C Composition based on oppositely-charged polypeptides |
| 09/22/2009 | CA2333086C Cocaine receptor binding ligands |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/22/2009 | CA2152351C Combination of a cholesterol biosynthesis inhibitor and a .beta.-lactam cholesterol absorption inhibitor |
| 09/17/2009 | WO2009114718A2 Methods and assays for detecting and treating hypoglycemia |
| 09/17/2009 | WO2009114597A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | WO2009114173A1 Azabicyclo [3. 2. i] octyl derivatives as 11 beta-hsdl modulators |
| 09/17/2009 | WO2009113952A1 Phytol as a cholesterol lowering agent |
| 09/17/2009 | WO2009113858A1 High protein liquid enteral nutritional composition |
| 09/17/2009 | WO2009113845A1 High protein liquid enteral nutritional composition |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113660A1 Microorganism producing cyclic compound |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113403A1 Anti-methicillin-resistant staphylococcus aureus agent and anti-vancomycin-resistant enterococcus agent |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112740A2 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 09/17/2009 | WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | WO2009112679A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112455A1 Medium chain dicarboxylic acids, their derivates and metabolic disorders |
| 09/17/2009 | WO2009112395A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | WO2009112155A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 09/17/2009 | WO2009111943A1 The compounds as the estrogen related receptors modulators and the uses thereof |
| 09/17/2009 | WO2009111889A1 Lymphocyte control of obesity and insulin resistance |
| 09/17/2009 | WO2009071850A8 Nanoparticles of therapeutic agents having low water solubility |
| 09/17/2009 | WO2009055783A3 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 09/17/2009 | WO2009046867A3 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 09/17/2009 | WO2009046866A3 Trap-14 as a therapeutic agent |
| 09/17/2009 | WO2009040070A3 Use of helodermin as a therapeutic agent |
| 09/17/2009 | US20090234018 Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same |
| 09/17/2009 | US20090233995 Use of drug combinations for treating insulin resistance |
| 09/17/2009 | US20090233986 Methods and compositions for using sax2 |
| 09/17/2009 | US20090233977 Method of Treating Atherosclerosis, dyslipidemias and related conditions |
| 09/17/2009 | US20090233971 GSK-3 Inhibitors |
| 09/17/2009 | US20090233936 Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes |
| 09/17/2009 | US20090233919 Thiazolopyridinone derivates as mch receptor antagonists |
| 09/17/2009 | US20090233918 2-(cyclic amino)-pyrimidone derivatives |
| 09/17/2009 | US20090233874 Including canagliflozin 1-(beta-D-glucopyransoyl)-4-methyl-3-(5-(4-fluorophenyl)-2 -thienylmethyl)benzene; sodium-dependent glucose transporter (SGLT); obesity, diabetes |
| 09/17/2009 | US20090233840 Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes |
| 09/17/2009 | US20090232892 Cellooligosaccharide-Containing Composition |
| 09/17/2009 | US20090232804 Humanized antibodies specific for von willebrand factor |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | CA2750859A1 The compounds as the estrogen related receptors modulators and the uses thereof |
| 09/17/2009 | CA2718394A1 Microorganism producing cyclic compound |
| 09/17/2009 | CA2718252A1 Bicyclic pyrrole compound |
| 09/17/2009 | CA2718038A1 Azabicyclo [3.2.1] octyl derivatives as 11 beta-hsdl modulators |
| 09/17/2009 | CA2718007A1 The use of medium chain dicarboxylic acids and derivates thereof in the treatment of metabolic disorders |
| 09/17/2009 | CA2717322A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | CA2716907A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | CA2716101A1 Phytol as a cholesterol lowering agent |
| 09/17/2009 | CA2715585A1 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 09/17/2009 | CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2712629A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100877A1 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 09/16/2009 | EP2100611A1 Glucose metabolism ameliorating agent |
| 09/16/2009 | EP2100604A1 Medium chain dicarboxylic acids and their derivates and metabolic disorders |
| 09/16/2009 | EP2100139A2 Biologically active compositions, methods for producing the same and biological applications |
| 09/16/2009 | EP2099793A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/16/2009 | EP2099791A1 Thienyl-containing glycopyranosyl derivatives as antidiabetics |
| 09/16/2009 | EP2099782A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 09/16/2009 | EP2099777A1 Urea glucokinase activators |
| 09/16/2009 | EP2099752A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 09/16/2009 | EP2099523A2 Methods for treating pompe disease |
| 09/16/2009 | EP2099449A1 Pharmaceutical composition for the treatment and prevention of diseases involving impotence |
| 09/16/2009 | EP2099448A1 Pharmaceutical composition for treatment and prevention of restenosis |
| 09/16/2009 | EP1765323B1 Use of furan alkyl for preparing an antidiabetic drug |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 09/16/2009 | CN101534825A Drug formulation containing fibrate medicament and process for producing the same |
| 09/16/2009 | CN101534823A Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 09/16/2009 | CN101532013A RNA for inhibiting Hepcidin, recombinant and application |
| 09/16/2009 | CN101531904A Bamboo leaves extract, preparing method and purpose thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531681A High-purity minodronic acid and preparation method thereof |
| 09/16/2009 | CN101531657A Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof |
| 09/16/2009 | CN101531638A Compound used as a regulator of estrogen-related receptor and applications thereof |
| 09/16/2009 | CN101530617A Pharmaceutical composition containing PPAR regulator and strontium salt |
| 09/16/2009 | CN101530593A Traditional Chinese medicine for treating diabetic numbness of extremities |
| 09/16/2009 | CN101530592A Traditional Chinese medicine for treating diabetic gastroparesis |
| 09/16/2009 | CN101530565A Chinese traditional medicine preparation used for curing diabetes and preparation method thereof |
| 09/16/2009 | CN101530564A Pharmaceutical composition for preventing and treating diabetes mellitus |
| 09/16/2009 | CN101530559A Composition having weight-losing effect |
| 09/16/2009 | CN101530558A Traditional Chinese medicine for lowering blood lipid |
| 09/16/2009 | CN101530555A Traditional Chinese medicine granules for treating diabetes mellitus |
| 09/16/2009 | CN101530554A Traditional Chinese medicine formula for treating diabetes mellitus, mixing ratio and preparation method thereof |
| 09/16/2009 | CN101530542A Oral pharmaceutical preparation of chinaroot greenbrier total aglycon and preparation method and application thereof |
| 09/16/2009 | CN101530538A Oral preparation for treating diabetes mellitus |
| 09/16/2009 | CN101530537A Formula for treating diabetes mellitus and preparation method thereof |
| 09/16/2009 | CN101530534A Oral pharmaceutical preparation of dioscorea panthaica total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530533A Oral pharmaceutical preparation of dioscorea zingiberensis wright total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530532A Oral pharmaceutical preparation of yam total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530523A Externally applied traditional Chinese medicine composition for treating diabetes mellitus |
| 09/16/2009 | CN101530517A Traditional Chinese compound for curing central obesity and nonalcoholic fatty liver disease and preparation method thereof |
| 09/16/2009 | CN101530515A Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate |